Stockreport

Oculis to Present at Upcoming February Investor Conferences

Oculis Holding AG  (OCS) 
PDF ZUG, Switzerland and BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to sa [Read more]